BioLife Solutions, Inc.
BLFS · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$20,184 | -$66,427 | -$139,805 | -$7,635 |
| Dep. & Amort. | $5,491 | $12,295 | $16,472 | $12,865 |
| Deferred Tax | -$64 | -$62 | -$5,238 | -$20,127 |
| Stock-Based Comp. | $30,923 | $31,670 | $25,334 | $13,956 |
| Change in WC | $227 | $1,467 | -$14,905 | -$3,531 |
| Other Non-Cash | -$7,962 | $8,559 | $109,653 | -$364 |
| Operating Cash Flow | $8,431 | -$12,498 | -$8,489 | -$4,836 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$3,227 | -$6,381 | -$10,385 | -$8,385 |
| Net Acquisitions | $60,392 | $0 | $0 | $1,559 |
| Inv. Purchases | -$18,415 | -$27,095 | -$53,116 | -$6,371 |
| Inv. Sales/Matur. | $21,918 | $56,169 | $8,920 | $6,371 |
| Other Inv. Act. | -$2,368 | -$4,856 | -$3,536 | -$5,816 |
| Investing Cash Flow | $58,300 | $17,837 | -$58,117 | -$12,642 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -$6,608 | -$498 | $17,836 | -$2,894 |
| Stock Issued | $202 | $10,244 | $192 | $1,273 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | -$377 | $845 | -$1,711 | -$1,157 |
| Financing Cash Flow | -$6,783 | $10,591 | $16,317 | -$2,778 |
| Forex Effect | $0 | $35 | -$108 | -$282 |
| Net Chg. in Cash | $59,948 | $15,965 | -$50,397 | -$20,586 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $35,438 | $19,473 | $69,870 | $90,456 |
| End Cash | $95,386 | $35,438 | $19,473 | $69,870 |
| Free Cash Flow | $5,204 | -$18,879 | -$18,874 | -$13,221 |